Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHORT: TASOX and Short Course Radiation in Operable Rectal Cancer
NCT04417699Phase 2Completed
- Start
- Jul 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trifluridine + tipiracil in rectal cancer. Started Jul 2022; status: completed.
02
Drugs
trifluridine + tipiracil
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT04417699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04417699.